These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26337905)

  • 1. Proton pump inhibitors for the treatment of cancer in companion animals.
    Walsh M; Fais S; Spugnini EP; Harguindey S; Abu Izneid T; Scacco L; Williams P; Allegrucci C; Rauch C; Omran Z
    J Exp Clin Cancer Res; 2015 Sep; 34(1):93. PubMed ID: 26337905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism.
    Fais S
    J Intern Med; 2010 May; 267(5):515-25. PubMed ID: 20433578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning of proton pump inhibitors in cancer therapy.
    Lu ZN; Tian B; Guo XL
    Cancer Chemother Pharmacol; 2017 Nov; 80(5):925-937. PubMed ID: 28861639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.
    Spugnini EP; Baldi A; Buglioni S; Carocci F; de Bazzichini GM; Betti G; Pantaleo I; Menicagli F; Citro G; Fais S
    J Transl Med; 2011 Dec; 9():221. PubMed ID: 22204495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.
    Spugnini EP; Buglioni S; Carocci F; Francesco M; Vincenzi B; Fanciulli M; Fais S
    J Transl Med; 2014 Aug; 12():225. PubMed ID: 25143012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors may reduce tumour resistance.
    De Milito A; Fais S
    Expert Opin Pharmacother; 2005 Jun; 6(7):1049-54. PubMed ID: 15957961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of clinical trials in veterinary oncology.
    Burton J; Khanna C
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):977-87. PubMed ID: 25174911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitors.
    Spugnini EP; Fais S
    Expert Opin Ther Pat; 2020 Jan; 30(1):15-25. PubMed ID: 31847622
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rationale for the use of proton pump inhibitors as antineoplastic agents.
    De Milito A; Marino ML; Fais S
    Curr Pharm Des; 2012; 18(10):1395-406. PubMed ID: 22360553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.
    Zabielska-Koczywąs K; Lechowski R
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29215573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving human cancer therapy through the evaluation of pet dogs.
    LeBlanc AK; Mazcko CN
    Nat Rev Cancer; 2020 Dec; 20(12):727-742. PubMed ID: 32934365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supporting the veterinary cancer patient on chemotherapy: neutropenia and gastrointestinal toxicity.
    Vail DM
    Top Companion Anim Med; 2009 Aug; 24(3):122-9. PubMed ID: 19732730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular acidity as favouring factor of tumor progression and metastatic dissemination.
    Calorini L; Peppicelli S; Bianchini F
    Exp Oncol; 2012 Jul; 34(2):79-84. PubMed ID: 23013757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onco-epidemiology of domestic animals and targeted therapeutic attempts: perspectives on human oncology.
    Di Cerbo A; Palmieri B; De Vico G; Iannitti T
    J Cancer Res Clin Oncol; 2014 Nov; 140(11):1807-14. PubMed ID: 24816783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrochemotherapy in Veterinary Oncology: State-of-the-Art and Perspectives.
    Spugnini EP; Baldi A
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):967-979. PubMed ID: 31176458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in tumour responses to cancer chemotherapy.
    Lawrence J; Cameron D; Argyle D
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking on cancer: treatment increases, improves for companion animals.
    Burns K
    J Am Vet Med Assoc; 2014 Jan; 244(2):140-4. PubMed ID: 24378021
    [No Abstract]   [Full Text] [Related]  

  • 20. Veterinary photodynamic therapy: a review.
    Buchholz J; Walt H
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):342-7. PubMed ID: 24284083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.